论文信息 - The neurofilament light chain is not stable in vitro

The neurofilament light chain is not stable in vitro

plant (BMT) patient group. More importantly, both the neurofilament increase and brain volume reduction observed in the year after BMT were so clearly different, and accompanied by clinical deterioration (Expanded Disability Status Scale [EDSS] dropped abruptly after conditioning and this drop was sustained over years), that there is no reason to doubt the occurrence of a related neurotoxicity.

C. Teunissen | A. Petzold | M. Koel-Simmelink | Marinus A. Blankenstein | P. Behradkia

[1] M. Filippi,et al. Evidence for acute neurotoxicity after chemotherapy , 2010, Annals of neurology.

[2] J. Fleming,et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.

[3] D. Arnold,et al. Brain atrophy after immunoablation and stem cell transplantation in multiple sclerosis , 2006, Neurology.

[4] A. Petzold. Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss , 2005, Journal of the Neurological Sciences.

[5] C. Polman,et al. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis , 2005, The Lancet Neurology.

[6] G. Giovannoni,et al. A specific ELISA for measuring neurofilament heavy chain phosphoforms. , 2003, Journal of immunological methods.

[7] A. Minagar. Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab , 2011 .